“Full house” lupus nephritis with negative serology: a case report

Authors

  • José L. Guerrero Servicio de nefrología, Hospital General de Manta, Manabí, Ecuador
  • Amparo N. Lucas Servicio de nefrología, Hospital General de Manta, Manabí, Ecuador
  • Gema Y. García Servicio de nefrología, Hospital General de Manta, Manabí, Ecuador
  • María L. Montesdeoca Servicio de nefrología, Hospital General de Manta, Manabí, Ecuador
  • Melissa M. Mendieta Servicio de nefrología, Hospital General de Manta, Manabí, Ecuador

DOI:

https://doi.org/10.18203/2320-6012.ijrms20252795

Keywords:

Lupus nephritis, Systemic lupus erythematosus, Kidney biopsy, Steroids

Abstract

Kidney disease is the leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). Among the histological types of lupus nephritis, membranous lupus nephritis accounts for only one-fifth of all cases, with immunofluorescence being essential for diagnosis. The long-term prognosis of lupus nephritis is uncertain, with a significant percentage progressing to stage 5D chronic kidney disease (10 to 20%). Existing evidence on the relative efficacy of different therapies is limited. The authors present the clinical case of a 28-year-old male patient with a kidney biopsy revealing lupus nephritis, in the absence of other clinical and laboratory manifestations of SLE. Until a few years ago, 40% of patients with severe forms of lupus nephritis progressed to death or chronic kidney failure within five years of disease onset. Today, this pessimistic prognosis has improved significantly thanks to anatomical, clinical, and therapeutic approaches.

Metrics

Metrics Loading ...

References

García-Mac Gregor E. Lupus eritematoso sistémico y vasculitis. Maracaibo (Venezuela): Editorial: Universidad del Zulia. 1992.

Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int. 1983;24(3):377. DOI: https://doi.org/10.1038/ki.1983.170

Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, et al. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q J Med. 1983;52(208):471.

Sloan RP, Schwartz MM, Korbet SM, Borok RZ. Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group. J Am Soc Nephrol. 1996;7(2):299. DOI: https://doi.org/10.1681/ASN.V72299

Tam LS, Li EK, Lai FM, Chan YK, Szeto CC. Mesangial lupus nephritis in Chinese is associated with a high rate of transformation to higher grade nephritis. Lupus. 2003;12(9):665-71. DOI: https://doi.org/10.1191/0961203303lu446oa

Aringer M, Karen C, David D, Ralph B, Marta M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151-9. DOI: https://doi.org/10.1136/annrheumdis-2018-214819

Musa R, Brent LH, Qurie A. Lupus Nephritis. 2021. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2021.

Downloads

Published

2025-08-29

How to Cite

Guerrero, J. L., Lucas, A. N., García, G. Y., Montesdeoca, M. L., & Mendieta, M. M. (2025). “Full house” lupus nephritis with negative serology: a case report. International Journal of Research in Medical Sciences, 13(9), 3801–3804. https://doi.org/10.18203/2320-6012.ijrms20252795

Issue

Section

Case Reports